Topics

Waves of sartan recalls lead to new FDA draft guidance

10:32 EDT 1 May 2019 | in-PharmaTechnologis

The US FDA has issued draft guidance on the process of voluntary recalls, after a series of recalls involving sartan contamination with carcinogenic impurities.

Original Article: Waves of sartan recalls lead to new FDA draft guidance

NEXT ARTICLE

More From BioPortfolio on "Waves of sartan recalls lead to new FDA draft guidance"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...